Table 5.

Availability of medications commonly used for treating arrhythmias in countries in the Asia Pacific region

	Direct oral anticoagulants	Class 1A drugs	Class 1C drugs	Amiodarone	Sotalol	Dofetilide
Brunei Darussalam	Dabigatran (funded); apixaban (available with defined criteria); rivaroxaban (partially funded)	Procainamide	Flecainide; propafenone	Available	Available	Not available
Cambodia	Dabigatran 150 mg, 110 mg, 75 mg; rivaroxaban 20 mg, 15 mg, 10 mg; apixaban 5 mg, 2.5 mg	Not available	Flecainide (tablet)	Available (IV, tablet)	Available (tablet)	Not available
China	Dabigatran; edoxaban; rivaroxaban	Not available	Propafenone	Available (dronedarone)	Available	Ibutilide
Indonesia	All available (none covered by NHS)	Not available	Propafenone (not covered by NHS)	Available	Not available	Not available
Japan	All available	Procainamide; disopyramide; quinidine; cibenzoline; pirmenol	Pilsicainide; flecainide; propafenone	Available	Available	Not available
Mongolia	Xarelto 20 mg, 15 mg	Not available	Propafenone	Available	Not available	Not available
New Zealand	Dabigatran (funded); rivaroxaban (funded); apixaban (not funded)	Disopyramide; quinidine†	Flecainide; propafenone	Available	Available	Not available
Philippines	All available	Not available	Flecainide	Available	Available	Not available
Singapore	All available	Disopyramide; quinidine†		Available (dronedarone)	Yes	No
South Korea	All available	Quinidine; procainamide∗; disopyramide∗	Flecainide; propafenone; pilsicainide	Available	Available	Not available
Taiwan	All available	Quinidine	Flecainide; propafenone	Available (dronedarone)	Sotalol∗	No
Thailand	All available	Not available	Flecainide; propafenone	Available	Not available	Not available

All available: dabigatran, apixaban, rivaroxaban, edoxaban.

NHS = national health service.

^∗Drugs that are not distributed although may be used.

^†Special authority.